Superworth

SpyGlass Pharma SGP

Medical - Instruments & Supplies, Healthcare
$33.64
+4.34%
Market cap
$1.1B
PE
n/m
one or more of the four quarters through 2026-06-30 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
not a meaningful number
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for SGP, by quarter
Income statementQ1 FY25Q2 FY25Q1 FY26Q2 FY26
R&D$6.1M$7.3M$8.5M$10.9M
SG&A$1.4M$2M$6.9M$11M
−$7.4M−$9.3M−$15.4M−$22M
Pre-tax income−$8.8M−$8.7M−$13.8M−$19.9M
$0$0$0$0
Net income−$8.8M−$8.7M−$13.8M−$19.9M
−$3.96−$3.81−$0.69−$0.59
2.2M2.3M19.9M33.4M

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest SpyGlass Pharma's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
SGPSpyGlass Pharma$1.1Bn/mn/an/mn/mn/m
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
IRMDIradimed$1B42.5×41.5×11.4×+11%26.8%
STAAStaar Surgical$1.3B356×144×3.7×+51%1.1%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
MOVMovado$710.9M17.7×13.4×1.0×+5%6.0%
LMATLemaitre Vascular$1.9B28.5×42.0×7.1×+12%25.0%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
UFPTUFP Technologies$2.2B30.6×25.6×3.5×+7%11.4%
Peer median$1.3B29.6×41.7×2.1×+8%7.7%

More on SpyGlass Pharma

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .